Skip to main content

A tricky wrinkle in Trump's Medicare Rx "Blueprint"

By CBS News  
   May 22, 2018

The Trump administration's "Blueprint" to lower drug prices and reduce patient costs made one thing clear: The government will not directly negotiate with drug companies to secure lower prescription prices.

Full story


Get the latest on healthcare leadership in your inbox.